Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas

被引:0
|
作者
Ohnishi, H
Kawamura, M
Hanada, R
Kaneko, Y
Tsunoda, Y
Hongo, T
Bessho, F
Yokomori, K
Hayashi, Y
机构
[1] UNIV TOKYO, FAC MED, DEPT PEDIAT, BUNKYO KU, TOKYO 113, JAPAN
[2] UNIV TOKYO, DEPT PEDIAT SURG, TOKYO, JAPAN
[3] SAITAMA CHILDRENS MED CTR, DEPT HEMATOL & ONCOL, IWATSUKI, SAITAMA, JAPAN
[4] SAITAMA CANC CTR HOSP, DEPT LAB MED, INA, SAITAMA, JAPAN
[5] SHOWA UNIV, SCH MED, DEPT SURG, TOKYO 142, JAPAN
[6] HAMAMATSU UNIV SCH MED, DEPT PEDIAT, SHIZUOKA, JAPAN
来源
GENES CHROMOSOMES & CANCER | 1996年 / 15卷 / 03期
关键词
D O I
10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the mutation of the TP53 gene in hepatoblastomas (HBLs) by using polymerase chain reaction-single strand conformation polymorphism and direct sequencing in 38 HBL tumor samples and in two HBL cell lines. We detected the TP53 gene mutation in an anaplastic hepatoblastoma cell line, but no aberration of the TP53 gene (exons 5-9) was found in tumor samples and in the other HBL cell line. The mutation of the cell line was a missense mutation from GAC (asparagine) to CAC (histidine) at codon 281, which was different from the G-to-T transversion of codon 249 that is frequently found in adult hepatocellular carcinomas (HCCs). In addition, we performed Southern blot analysis of the MDM2 gene, but we did not find MDM2 gene amplification in 19 cases tested. Our results suggest that, in contrast to the findings in HCCs in adults, TP53 gene aberrations are not involved in the development or progression of HBLs in children. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [21] NARROW SPECTRUM OF INFREQUENT P53 MUTATIONS AND ABSENCE OF MDM2 AMPLIFICATION IN EWING TUMORS
    KOVAR, H
    AUINGER, A
    JUG, G
    ARYEE, D
    ZOUBEK, A
    SALZERKUNTSCHIK, M
    GADNER, H
    ONCOGENE, 1993, 8 (10) : 2683 - 2690
  • [22] P53 MUTATIONS, AMPLIFICATION OF THE MDM2 GENE, AND INFECTION OF HPV IN JAPANESE ESOPHAGEAL CANCERS
    ISHIZAKI, K
    SHIBAGAKI, I
    WAGATA, T
    IMAMURA, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 200 - 200
  • [23] TP53 and MDM2 Gene Polymorphisms, Gene-Gene Interaction, and Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis
    Peng, Qiliu
    Lao, Xianjun
    Chen, Zhiping
    Lai, Hao
    Deng, Yan
    Wang, Jian
    Mo, Cuiju
    Sui, Jingzhe
    Wu, Junrong
    Zhai, Limin
    Yang, Shi
    Qin, Xue
    Li, Shan
    PLOS ONE, 2013, 8 (12):
  • [24] Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinoma
    Qian, W
    Hu, LF
    Chen, F
    Wang, YS
    Magnusson, KP
    Kashuba, E
    Klein, G
    Wiman, KG
    ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1995, 31B (05): : 328 - 332
  • [25] Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma
    Ohnstad, Hege O.
    Castro, Russell
    Sun, Jinchang
    Heintz, Karen-Marie
    Vassilev, Lyubomir T.
    Bjerkehagen, Bodil
    Kresse, Stine H.
    Meza-Zepeda, Leonardo A.
    Myklebost, Ola
    CANCER, 2013, 119 (05) : 1013 - 1022
  • [26] TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds
    Chakraborty, Rituraj
    Dutta, Anupam
    Mukhopadhyay, Rupak
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [27] TP53 GENE MUTATIONS IN PROSTATE CANCER PROGRESSION
    Ecke, Th. H.
    Schlechte, H. H.
    Schiemenz, K.
    Sachs, M. D.
    Lenk, S. V.
    Rudolph, B. D.
    Loening, S. A.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4055 - 4056
  • [28] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [29] Role in tumorigenesis of silent mutations in the TP53 gene
    Strauss, BS
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 457 (1-2) : 93 - 104
  • [30] TP53 Gene Mutations in Prostate Cancer Progression
    Ecke, Thorsten H.
    Schlechte, Horst H.
    Schiemenz, Katrin
    Sachs, Markus D.
    Lenk, Severin V.
    Rudolph, Birgit D.
    Loening, Stefan A.
    ANTICANCER RESEARCH, 2010, 30 (05) : 1579 - 1586